Gharpure Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 34 Year, 16 Days
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 0.68 M
- Revenue Growth %
- Net Worth -0.86%
- Total Assets %
About Gharpure Laboratories
Gharpure Laboratories Private Limited (GLPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 January 1991 and has a history of 34 years. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹0.68 M.
Yashwant Gharpure and Prabha Gharpure serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1991PTC060028
-
Company No.
060028
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jan 1991
-
Date of AGM
30 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Gharpure Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabha Gharpure
|
Director | 28-Jan-1991 | Current |
|
Yashwant Gharpure
|
Director | 28-Jan-1991 | Current |
Financial Performance of Gharpure Laboratories.
Gharpure Laboratories Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gharpure Laboratories?
In 2018, Gharpure Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gharpure Consulting Engineers Pvt LtdYashwant Gharpure and Prabha Gharpure are mutual person
-
Industrial Poly-Clinic (India) Private LimitedYashwant Gharpure and Prabha Gharpure are mutual person
Charges (Loans)
₹0.68 M
₹0
Charges Breakdown by Lending Institutions
- The Maharashtra State Financial Corporation : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 1995 | The Maharashtra State Financial Corporation | ₹0.68 M | Open |
How Many Employees Work at Gharpure Laboratories?
Unlock and access historical data on people associated with Gharpure Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gharpure Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gharpure Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.